On March 21, 2016 Myriad Genetics, Inc. (NASDAQ:MYGN), a leader in molecular diagnostics and personalized medicine, and Access Health, an educational program focused on health and wellness, reported that they will air an educational program on hereditary cancer that will appear on Lifetime (Press release, Myriad Genetics, MAR 21, 2016, View Source [SID:1234509769]). The program, titled "Hereditary Cancer Risk Assessment and Testing: The Answer Is in Your DNA," will run on Wednesday, March 30, 2016 7:30 am (ET/PT) and again on Wednesday, April 6, 2016 7:30 am (ET/PT).
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Individuals diagnosed with hereditary cancer syndromes such as Lynch Syndrome and Hereditary Breast and Ovarian Cancer Syndrome are at significantly higher risk of developing cancer than the general population. In this special episode of Access Health, viewers will hear from experts in the field of hereditary cancer, including certified genetic counselor Marianne Lotito and Angelina Jolie’s breast surgeon, Dr. Kristi Funk.
With regard to the show, Dr. Kristi Funk, M.D., said, "I am excited to be a part of this special episode of Access Health which educates individuals on the importance of cancer family history and the role genetic testing plays in understanding both individual cancer risk and related medical management options."
The program discusses the value of knowing personal and family cancer history, follows the inspirational journeys of two families affected by hereditary cancer and highlights how genetic testing positively impacted their lives and that of their families. The program also discusses hereditary cancer resources, including Myriad’s Hereditary Cancer Quiz that helps individuals learn about their hereditary cancer risk. This quiz is an online resource that helps individuals evaluate their personal/family cancer history and whether they may be candidates for genetic testing. It then generates a family history overview that can be shared with healthcare providers.
"We are very excited to support this Lifetime program, which is a broad, powerful resource for people seeking answers on a variety of important health questions related to genetic testing and cancer," said Bret Christensen, general manager, Preventive Care, Myriad Genetic Laboratories. "Our goal is to educate the public and to empower all Americans to live healthier lives. The Hereditary Cancer Quiz is a quick way for people to determine if they have any red flags for hereditary cancer."
To take the Hereditary Cancer Quiz, please visit View Source